Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Equilibrium and Balance01:15

Equilibrium and Balance

5.2K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
5.2K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

528
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
528
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

959
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
959
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

380
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
380
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

406
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
406
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

723
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
723

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methods for tagging whale sharks: insights into performance and best practices with a focus on clamp attachments.

Animal biotelemetry·2026
Same author

Health Care Provider Perceptions of Screening for Early-Stage Type 1 Diabetes-A Survey Study.

Diabetes, obesity & metabolism·2026
Same author

Anticipatory vibrotactile cues about upcoming turns reduce motion sickness: A study with car passengers on public roads.

Applied ergonomics·2026
Same author

"Stand your ground!" Defending oneself against cue-induced food craving in the context of the Sword-and-Shield-Hypothesis of embodiment.

Appetite·2026
Same author

Effects of Psychological Interventions on Itch, Scratching, and Excoriations: A Systematic Review and Meta-analysis.

Acta dermato-venereologica·2026
Same author

Vaccine ambassadors: An educational model to empower youth and spread awareness of vaccines in Detroit.

American journal of infection control·2026
Same journal

A portable solution for simultaneous human movement and mobile EEG acquisition: readiness potential for basketball free-throw shooting.

Experimental brain research·2026
Same journal

Effects of tDCS and tACS on operant tactile training: investigating individual differences in neuromodulation efficacy.

Experimental brain research·2026
Same journal

Investigating the effects of different exercise protocols on depressive-like behaviors and brain-derived neurotrophic factor (BDNF) in rodents: a systematic review.

Experimental brain research·2026
Same journal

Inward platform translations during treadmill walking enhance lateral weight shift and paretic leg engagement in chronic stroke.

Experimental brain research·2026
Same journal

Effects of lumbar disc injury and nociception on trunk motor control during rat locomotion.

Experimental brain research·2026
Same journal

Changes in synergy formation and modulation during cyclic finger force production tasks in female adults with dystonic cerebral palsy.

Experimental brain research·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.4K

Chewing gum reduces visually induced motion sickness.

Mara Kaufeld1, Katharina De Coninck2,3, Jennifer Schmidt3,4

  • 1Human Systems Engineering (MMS), Fraunhofer Institute for Communication, Information Processing and Ergonomics (FKIE), Zanderstr. 5, 53111, Bonn, Germany. mara.kaufeld@fkie.fraunhofer.de.

Experimental Brain Research
|January 8, 2022
PubMed
Summary
This summary is machine-generated.

Chewing gum effectively reduces visually induced motion sickness (VIMS) during virtual reality (VR) experiences. This gustatory-motor stimulation offers a simple, accessible method to improve VR comfort and acceptance in training and clinical settings.

Keywords:
Chewing gumGingerSimulator sicknessVirtual realityVisually induced motion sickness

More Related Videos

Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
06:18

Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation

Published on: February 7, 2020

7.6K
Long-term Sensory Conflict in Freely Behaving Mice
06:12

Long-term Sensory Conflict in Freely Behaving Mice

Published on: February 20, 2019

6.8K

Related Experiment Videos

Last Updated: Oct 7, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.4K
Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
06:18

Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation

Published on: February 7, 2020

7.6K
Long-term Sensory Conflict in Freely Behaving Mice
06:12

Long-term Sensory Conflict in Freely Behaving Mice

Published on: February 20, 2019

6.8K

Area of Science:

  • Human-Computer Interaction
  • Neuroscience
  • Sensory Science

Background:

  • Visually induced motion sickness (VIMS) is a significant challenge limiting virtual reality (VR) adoption.
  • Current countermeasures include mechanical stimulation and attention diversion, but a simple, integrated solution is needed.

Purpose of the Study:

  • To investigate the efficacy of chewing gum as a countermeasure against VIMS.
  • To determine if gustatory-motor stimulation from chewing gum reduces VIMS symptoms during VR exposure.

Main Methods:

  • 77 subjects participated in a 15-minute VR helicopter flight.
  • Participants were assigned to control, peppermint gum, or ginger gum groups.
  • VIMS was assessed using the Simulator Sickness Questionnaire (SSQ) and Fast Motion Sickness Scale (FMS).

Main Results:

  • Chewing gum significantly reduced peak FMS scores by 2.05 points compared to the control group (p < 0.01).
  • Both peppermint and ginger gum groups reported lower VIMS severity.
  • Pleasant taste ratings correlated with reduced VIMS, suggesting a sensory component to the effect.

Conclusions:

  • Chewing gum serves as an effective and accessible countermeasure for VIMS.
  • The gustatory-motor stimulation and pleasant taste contribute to mitigating VR-induced motion sickness.
  • Chewing gum presents a practical solution to enhance VR user experience in diverse applications.